Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: Relationship to neurotoxicity

Journal of Neurochemistry

Volumn 71, Issue 6, 1998, Pages 2322-2329

  Liu, Yuanbin ^a   Schubert, David ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

3 (4,5 Dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide; Alzheimer's disease; Amyloid fibrils; Amyloidosis; Steroid sex hormones; Pleated sheet

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID; ESTRADIOL; FORMAZAN; GLUCAGON; INSULIN; PROGESTERONE; SEX HORMONE;

AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; CHRONOLOGY; CONTROLLED STUDY; DRUG MECHANISM; EXOCYTOSIS; HIPPOCAMPUS; INTRACELLULAR TRANSPORT; MEMBRANE VESICLE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RAT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0031741751     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71062322.x     Document Type: Article

References (38)

1. 2+-dependent late phase. J. Neurochem. 67, 2074-2078.
2. Altman F. P. (1976) Tetrazolium salts and formazans. Prog. Histochem. Cytochem. 9, 1-56.
3. Beaven G. H., Gratzer W. B., and Davies H. G. (1969) Formation and structure of gels and fibrils from glucagon. Eur. J. Biochem. 11, 37-42.
4. Behl C., Davis J. B., Cole G. M., and Schubert D. (1992) Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-952.
5. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
6. Behl C., Widmann M., Trapp T., and Holsboer F. (1995) 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482.
7. Booth D. R., Sunde M., Bellotti V., Robinson C. V., Hutchinson W. L., Fraser P. E., Hawkins P. N., Dobson C. M., Radford S. E., Blake C. C. F., and Pepys M. B. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787-793.
8. Burke M. J. and Rougvie M. A. (1972) Cross-β protein structures. I. Insulin fibrils. Biochemistry 11, 2435-2439.
9. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F., and Caughey W. S. (1991) Secondary structure analysis of the scrapie-associated protein PrP27-30 in water by infrared spectroscopy. Biochemistry 30, 7672-7680.
10. Glenner G. G. (1980) Amyloid deposits and amyloidosis: the beta-fibrilloses. N. Engl. J. Med. 302, 1283-1292 (Pt. I) and 1333-1343 (Pt. II).
11. Glenner G. G. (1980) Amyloid deposits and amyloidosis: the beta-fibrilloses. N. Engl. J. Med. 302, 1283-1292 (Pt. I) and 1333-1343 (Pt. II).
12. Glenner G. G. and Page D. L. (1976) Amyloid, amyloidosis, and amyloidogenesis. Int. Rev. Exp. Pathol. 15, 1-92.
13. Glenner G. G., Eanes E. D., Bladen H. A., Linke R. P., and Termine J. D. (1974) A comparison of native amyloid with synthetic protein fibrils. J. Histochem. Cytochem. 22, 1141-1158.
14. Han H., Weinreb P. H., and Lansbury P. T. Jr. (1995) The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative diseases? Chem. Biol. 2, 163-169.
15. Iwai A., Yoshimoto M., Masliah E., and Saitoh T. (1995) Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 34, 10139-10145.
16. Kawas C., Resnick R., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D. D., and Metter E. (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease. Neurology 48, 1517-1521.
17. Klunk W. E., Pettegrew J. W., and Abraham D. J. (1989) Two simple methods for quantifying low-affinity dye-substrate binding. J. Histochem. Cytochem. 37, 1293-1297.
18. Lai Z., Colón W., and Kelly J. W. (1995) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35, 6470-6482.
19. Liu Y. and Schubert D. (1997) Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J. Neurochem. 69, 2285-2293.
20. Liu Y., Peterson D. A., Kimura H., and Schubert D. (1997a) The mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69, 581-593.
21. Liu Y., Dargusch R., and Schubert D. (1997b) Beta amyloid toxicity does not require RAGE protein. Biochem. Biophys. Res. Commun. 237, 37-40.
22. Lorenzo A. and Yankner B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
23. May P. C., Boggs L. N., and Fuson K. S. (1993) Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-β neurotoxicity. J. Neurochem. 61, 2330-2333.
24. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity. J. Immunol. Methods 65, 55-63.
25. Nussbaum R. L. and Polymeropoulos M. H. (1997) Genetics of Parkinson's disease. Hum. Mol. Genet 6, 1687-1691.
26. Paganini-Hill A. and Henderson V. W. (1994) Estrogen deficiency and risk of Alzheimer's disease. Am. J. Epidemiol. 140, 256-261.
27. Perutz M. F., Johnson T., Suzuki M., and Finch J. T. (1994) Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91, 5355-5358.
28. Pike C. J., Cummings B. J., and Cotman C. W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
29. Prusiner S. B., McKinley M. P., Bowman K. A., Bendheim P. E., Bolton D. C., Groth D. F., and Glenner G. G. (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349-358.
30. Scherzinger E., Lurz R., Turmaine M., Mangiarini L., Hollenbach B., Hasenbank R., Bates G. P., Davies S. W., Lehrach H., and Wanker E. E. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558.
31. Schubert D., Heinemann S., Carlisle W., Tarika H., Kimes B., Steinbach J. H., Culp W., and Brandt B. L. (1974) Clonal cell lines from the rat central nervous system. Nature 249, 224-227.
32. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., and Kimura H. (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92, 1989-1993.
33. Shearman M. S., Ragan C. I., and Iversen L. L. (1994) Inhibition of PC-12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA 91, 1470-1474.
34. Sipe J. D. (1992) Amyloidosis. Annu. Rev. Biochem. 61, 947-975.
35. Tang M., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
36. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D. A., Kondo J., Ihara Y., and Saitoh T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 11282-11286.
37. Yankner B. A. (1996) Mechanism of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
38. Yankner B. A., Duffy L. K., and Kirscher D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250, 279-282.